Skip to content
2000
image of Post-Herpetic Neuralgia: Review of Pathophysiology, Mechanisms, and Drug Treatment

Abstract

Post-herpetic neuralgia (PHN) is the most common complication of Herpes zoster infection. Although numerous targeted therapeutic drugs have been developed, it is difficult to achieve a complete cure. Abnormalities in neural circuits, ion channels, inflammatory factors, and gene regulation are crucial factors contributing to the development of PNH; however, the underlying mechanism remains unclear. Therefore, a comprehensive understanding of the underlying mechanisms of PNH is critical for advancing research and developing novel therapeutic strategies. Based on the latest findings, we systematically reviewed the current understanding of PHN mechanisms and corresponding treatment options and provided a comprehensive reference for future studies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X396405250924103619
2025-10-27
2025-12-15

  • From This Site

    /content/journals/cn/10.2174/011570159X396405250924103619
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. He Y. He J. Miao F. Fan Y. Zhang F. Wang Z. Wu Y. Zhao Y. Yang P. A bibliometric and visualization analysis of global re-search on postherpetic neuralgia from 2000 to 2022. A review. Medicine 2023 102 45 e34502 10.1097/MD.0000000000034502 37960786
    [Google Scholar]
  2. Chen L.K. Arai H. Chen L.Y. Chou M.Y. Djauzi S. Dong B. Kojima T. Kwon K.T. Leong H.N. Leung E.M.F. Liang C.K. Liu X. Mathai D. Pan J.Y. Peng L.N. Poblete E.R.S. Poi P.J.H. Reid S. Tantawichien T. Won C.W. Looking back to move for-ward: A twenty-year audit of herpes zoster in asia-pacific. BMC Infect. Dis. 2017 17 1 213 10.1186/s12879‑017‑2198‑y 28298208
    [Google Scholar]
  3. Yang F. Yu S. Fan B. Liu Y. Chen Y.X. Kudel I. Concialdi K. DiBonaventura M. Hopps M. Hlavacek P. Cappelleri J.C. Sadosky A. Parsons B. Udall M. The epidemiology of herpes zoster and postherpetic neuralgia in china: Results from a cross-sectional study. Pain Ther. 2019 8 2 249 259 10.1007/s40122‑019‑0127‑z 31218562
    [Google Scholar]
  4. Hillebrand K. Bricout H. Schulze-Rath R. Schink T. Garbe E. Incidence of herpes zoster and its complications in Germany, 2005–2009. J. Infect. 2015 70 2 178 186 10.1016/j.jinf.2014.08.018 25230396
    [Google Scholar]
  5. Forbes H.J. Thomas S.L. Smeeth L. Clayton T. Farmer R. Bhaskaran K. Langan S.M. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 2016 157 1 30 54 10.1097/j.pain.0000000000000307 26218719
    [Google Scholar]
  6. Park C. John H. Lee J. Hong S. Kim M. Park S. Kim J.H. The relative frequency of pruritus in postherpetic neuralgia patients pre-senting to the pain clinic and associative factors. Medicine 2022 101 35 e30208 10.1097/MD.0000000000030208 36107606
    [Google Scholar]
  7. Jiang X. Li Y. Chen N. Zhou M. He L. Corticosteroids for preventing postherpetic neuralgia. Cochrane Libr. 2023 2023 12 CD005582 10.1002/14651858.CD005582.pub5 38050854
    [Google Scholar]
  8. Baron R. Binder A. Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010 9 8 807 819 10.1016/S1474‑4422(10)70143‑5 20650402
    [Google Scholar]
  9. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia 2018 38 1 1 211 10.1177/0333102417738202 29368949
    [Google Scholar]
  10. DaSilva A.F. DosSantos M.F. The role of sensory fiber demography in trigeminal and postherpetic neuralgias. J. Dent. Res. 2012 91 1 17 24 10.1177/0022034511411300 21670221
    [Google Scholar]
  11. Harding S.P. Lipton J.R. Wells J.C. Natural history of herpes zoster ophthalmicus: Predictors of postherpetic neuralgia and ocular in-volvement. Br. J. Ophthalmol. 1987 71 5 353 358 10.1136/bjo.71.5.353 3495293
    [Google Scholar]
  12. Gross G.E. Eisert L. Doerr H.W. Fickenscher H. Knuf M. Maier P. Maschke M. Müller R. Pleyer U. Schäfer M. Sunderkötter C. Werner R.N. Wutzler P. Nast A. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J. Dtsch. Dermatol. Ges. 2020 18 1 55 78 10.1111/ddg.14013 31951098
    [Google Scholar]
  13. Ou M. Chen J. Yang S. Xiao L. Xiong D. Wu S. Rodent models of postherpetic neuralgia: How far have we reached? Front. Immunol. 2023 14 1026269 10.3389/fimmu.2023.1026269 37020565
    [Google Scholar]
  14. Zhang D. Ma L. Tan X. Deng W. Wen S. Li Y. Qin B. Cao S. Yu T. Intradermal miR-16–5p targets Akt3 and reduces RTX-induced postherpetic neuralgia-mimic pain in mice. Eur. J. Pharmacol. 2023 946 175665 10.1016/j.ejphar.2023.175665 36940911
    [Google Scholar]
  15. Butler D.C. Berger T. Elmariah S. Kim B. Chisolm S. Kwatra S.G. Mollanazar N. Yosipovitch G. Chronic Pruritus. JAMA 2024 331 24 2114 2124 10.1001/jama.2024.4899 38809527
    [Google Scholar]
  16. Chen K. Wang M. Long D. Zou D. Li X. Wang R. Wang Y. Yang L. Cerebrospinal fluid proteomic profiles in patients with postherpetic neuralgia. J. Proteome Res. 2023 22 12 3879 3892 10.1021/acs.jproteome.3c00547 37966014
    [Google Scholar]
  17. Bagues A. Hu J. Alshanqiti I. Chung M.K. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain. Pharmacol. Ther. 2024 259 108668 10.1016/j.pharmthera.2024.108668 38782121
    [Google Scholar]
  18. Cohen E.J. Jeng B.H. Herpes zoster: A brief definitive review. Cornea 2021 40 8 943 949 10.1097/ICO.0000000000002754 34029242
    [Google Scholar]
  19. Leung J. Harpaz R. Molinari N.A. Jumaan A. Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: Evaluation of impact of varicella vaccination. Clin. Infect. Dis. 2011 52 3 332 340 10.1093/cid/ciq077 21217180
    [Google Scholar]
  20. Kawai K. Yawn B.P. Wollan P. Harpaz R. Increasing incidence of Herpes zoster over a 60-year period from a population-based study. Clin. Infect. Dis. 2016 63 2 221 226 10.1093/cid/ciw296 27161774
    [Google Scholar]
  21. Yawn B.P. Saddier P. Wollan P.C. Sauver J.L.S. Kurland M.J. Sy L.S. A population-based study of the incidence and complication rates of Herpes zoster before zoster vaccine introduction. Mayo Clin. Proc. 2007 82 11 1341 1349 10.4065/82.11.1341 17976353
    [Google Scholar]
  22. Patil A. Goldust M. Wollina U. Herpes zoster: A review of clinical manifestations and management. Viruses 2022 14 2 192 10.3390/v14020192 35215786
    [Google Scholar]
  23. Tang J. Zhang Y. Liu C. Zeng A. Song L. Therapeutic strategies for postherpetic neuralgia: Mechanisms, treatments, and perspec-tives. Curr. Pain Headache Rep. 2023 27 9 307 319 10.1007/s11916‑023‑01146‑x 37493871
    [Google Scholar]
  24. Kost R.G. Straus S.E. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N. Engl. J. Med. 1996 335 1 32 42 10.1056/NEJM199607043350107 8637540
    [Google Scholar]
  25. Werner R.N. Ghoreschi K. Herpes zoster—prevention, diagnosis, and treatment. Hautarzt 2022 73 6 442 451 10.1007/s00105‑022‑04992‑9 35477786
    [Google Scholar]
  26. Wollina U. Variations in herpes zoster manifestation. Indian J. Med. Res. 2017 145 3 294 298 10.4103/ijmr.IJMR_1622_16 28749391
    [Google Scholar]
  27. Chen F. Chen F. Shang Z. Shui Y. Wu G. Liu C. Lin Z. Lin Y. Yu L. Kang D. Tao W. Li Y. White matter microstructure degenerates in patients with postherpetic neuralgia. Neurosci. Lett. 2017 656 152 157 10.1016/j.neulet.2017.07.023 28729077
    [Google Scholar]
  28. Watson C.P.N. Deck J.H. Morshead C. Van der Kooy D. Evans R.J. Post-herpetic neuralgia: Further post-mortem studies of cases with and without pain. Pain 1991 44 2 105 117 10.1016/0304‑3959(91)90124‑G 1711192
    [Google Scholar]
  29. Muley M.M. Krustev E. Reid A.R. McDougall J.J. Prophylactic inhibition of neutrophil elastase prevents the development of chronic neuropathic pain in osteoarthritic mice. J. Neuroinflammation 2017 14 1 168 10.1186/s12974‑017‑0944‑0 28835277
    [Google Scholar]
  30. Hope-Simpson R.E. The nature of Herpes zoster: A long-term study and a new hypothesis. Proc. R. Soc. Med. 1965 58 1 9 20 10.1177/003591576505800106 14267505
    [Google Scholar]
  31. Shafran S.D. Tyring S.K. Ashton R. Decroix J. Forszpaniak C. Wade A. Paulet C. Candaele D. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: A randomized, multicenter, dou-ble-blind clinical trial. J. Clin. Virol. 2004 29 4 248 253 10.1016/S1386‑6532(03)00164‑1 15018852
    [Google Scholar]
  32. Shen M.C. Lin H.H. Lee S.S. Chen Y.S. Chiang P.C. Liu Y.C. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated Herpes zoster. J. Microbiol. Immunol. Infect. 2004 37 2 75 81 15181487
    [Google Scholar]
  33. Sampathkumar P. Drage L.A. Martin D.P. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin. Proc. 2009 84 3 274 280 10.4065/84.3.274 19252116
    [Google Scholar]
  34. Wood M.J. Johnson R.W. McKendrick M.W. Taylor J. Mandal B.K. Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute Herpes zoster. N. Engl. J. Med. 1994 330 13 896 900 10.1056/NEJM199403313301304 8114860
    [Google Scholar]
  35. Whitley R.J. Weiss H. Gnann J.W. Tyring S. Mertz G.J. Pappas P.G. Schleupner C.J. Hayden F. Wolf J. Soong S. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. Ann. Intern. Med. 1996 125 5 376 383 10.7326/0003‑4819‑125‑5‑199609010‑00004 8702088
    [Google Scholar]
  36. Klein N.P. Bartlett J. Fireman B. Marks M.A. Hansen J. Lewis E. Aukes L. Saddier P. Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records. BMJ 2023 383 e076321 10.1136/bmj‑2023‑076321 37940142
    [Google Scholar]
  37. Harpaz R Ortega-Sanchez IR Seward JF Prevention of herpes zoster: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep 2008 57 RR-5 1 30 18528318
    [Google Scholar]
  38. Harbecke R. Cohen J.I. Oxman M.N. Herpes zoster vaccines. J. Infect. Dis. 2021 224 12 S429 S442 10.1093/infdis/jiab387 34590136
    [Google Scholar]
  39. Gupta S. Arasaratnam R.J. Solow E.B. Bajaj P. A medical records review study assessing safety of zoster vaccine recombinant, adju-vanted in patients with Rheumatic disease. J. Clin. Rheumatol. 2022 28 2 e528 e531 10.1097/RHU.0000000000001790 34609337
    [Google Scholar]
  40. Younes S. Sigireddi R.R. Raviskanthan S. Mortensen P.W. Lee A.G. Bilateral myelin oligodendrocyte glycoprotein-related optic neu-ritis presenting after herpes zoster subunit vaccination. Can. J. Ophthalmol. 2021 56 5 e157 e160 10.1016/j.jcjo.2021.02.036 33775591
    [Google Scholar]
  41. Johnson R.W. Wasner G. Saddier P. Baron R. Postherpetic neuralgia: Epidemiology, pathophysiology and management. Expert Rev. Neurother. 2007 7 11 1581 1595 10.1586/14737175.7.11.1581 17997705
    [Google Scholar]
  42. Fields H.L. Rowbotham M. Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol. Dis. 1998 5 4 209 227 10.1006/nbdi.1998.0204 9848092
    [Google Scholar]
  43. Baron R. Saguer M. Postherpetic neuralgia: Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain 1993 116 6 1477 1496 10.1093/brain/116.6.1477 8293282
    [Google Scholar]
  44. Chun-jing H. yi-ran, L.; hao-xiong, N. Effects of dorsal root ganglion destruction by adriamycin in patients with postherpetic neuralgia. Acta Cir. Bras. 2012 27 6 404 409 10.1590/S0102‑86502012000600008 22666758
    [Google Scholar]
  45. Devor M. Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: The ectopic pacemaker hypothesis. Pain Rep. 2018 3 6 e702 10.1097/PR9.0000000000000702 30706041
    [Google Scholar]
  46. Ngo A.L. Urits I. Yilmaz M. Fortier L. Anya A. Oh J.H. Berger A.A. Kassem H. Sanchez M.G. Kaye A.D. Urman R.D. Her-ron E.W. Cornett E.M. Viswanath O. Postherpetic neuralgia: Current evidence on the topical film-forming spray with bupivacaine hy-drochloride and a review of available treatment strategies. Adv. Ther. 2020 37 5 2003 2016 10.1007/s12325‑020‑01335‑9 32297285
    [Google Scholar]
  47. Hadley G.R. Gayle J.A. Ripoll J. Jones M.R. Argoff C.E. Kaye R.J. Kaye A.D. Post-herpetic neuralgia: A review. Curr. Pain Headache Rep. 2016 20 3 17 10.1007/s11916‑016‑0548‑x 26879875
    [Google Scholar]
  48. Woolf C.J. Max M.B. Mechanism-based pain diagnosis: Issues for analgesic drug development. Anesthesiology 2001 95 1 241 249 10.1097/00000542‑200107000‑00034 11465563
    [Google Scholar]
  49. Xû G. Xú G. Feng Y. Tang W.Z. Lv Z.W. Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia: A single-center randomized controlled trial. Am. J. Phys. Med. Rehabil. 2014 93 4 287 298 10.1097/PHM.0000000000000002 24196971
    [Google Scholar]
  50. Lin C.S. Lin Y.C. Lao H.C. Chen C.C. Interventional treatments for postherpetic neuralgia: A systematic review. Pain Physician 2019 3 22 209 228 10.36076/ppj/2019.22.209 31151330
    [Google Scholar]
  51. Lin H. Cao G. Yang Z. Jin G. Huang B. Huang C. Yao M. Shao J. Computed tomography-guided radiofrequency ablation of the cervical dorsal root ganglia in 27 patients with cervical and occipital postherpetic neuralgia. Med. Sci. Monit. 2021 27 e932612 10.12659/MSM.932612 34654795
    [Google Scholar]
  52. Gónima Valero E. Mendoza W.A.S. Sarmiento D.A. Amaya S. Analgesic treatment approach for postherpetic neuralgia: A narrative review. J. Pain Palliat. Care Pharmacother. 2023 37 2 184 193 10.1080/15360288.2023.2174632 36731106
    [Google Scholar]
  53. Stepanović A. Kolšek M. Kersnik J. Erčulj V. Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien. Klin. Wochenschr. 2015 127 9-10 369 374 10.1007/s00508‑014‑0669‑3 25471002
    [Google Scholar]
  54. Ro L.S. Chang K.H. Neuropathic pain: Mechanisms and treatments. Chang Gung Med. J. 2005 28 9 597 605 16323550
    [Google Scholar]
  55. Isagulyan E. Tkachenko V. Semenov D. Asriyants S. Dorokhov E. Makashova E. Aslakhanova K. Tomskiy A. The effective-ness of various types of electrical stimulation of the spinal cord for chronic pain in patients with postherpetic neuralgia: A literature re-view. Pain Res. Manag. 2023 2023 1 8 10.1155/2023/6015680 37007861
    [Google Scholar]
  56. Cai S. Du L. Xiang Q. Liu C. Zhang Y. Peng Z. Kang X. Feng Z. Comparing the efficacy and safety of high-voltage and standard-voltage pulsed radiofrequency for the treatment of postherpetic neuralgia: A pooled analysis from randomized controlled trials. Heliyon 2024 10 9 e30525 10.1016/j.heliyon.2024.e30525 38765102
    [Google Scholar]
  57. Mineroff J. Uwakwe L.N. Mojeski J. Jagdeo J. Using botulinum toxin A to treat postherpetic itch. Arch. Dermatol. Res. 2023 315 10 2971 2972 10.1007/s00403‑023‑02726‑y 37747568
    [Google Scholar]
  58. Zhao P. Jiang T. Wang H. Jia X. Li A. Gong H. Li X. Upper brainstem cholinergic neurons project to ascending and descending circuits. BMC Biol. 2023 21 1 135 10.1186/s12915‑023‑01625‑y 37280580
    [Google Scholar]
  59. Zhao P. Wang H. Li A. Sun Q. Jiang T. Li X. Gong H. The mesoscopic connectome of the cholinergic pontomesencephalic teg-mentum. Front. Neuroanat. 2022 16 843303 10.3389/fnana.2022.843303 35655583
    [Google Scholar]
  60. Finnerup N.B. Kuner R. Jensen T.S. Neuropathic pain: From mechanisms to treatment. Physiol. Rev. 2021 101 1 259 301 10.1152/physrev.00045.2019 32584191
    [Google Scholar]
  61. Shin H.J. Na H.S. Do S.H. Magnesium and pain. Nutrients 2020 12 8 2184 10.3390/nu12082184 32718032
    [Google Scholar]
  62. Kim Y.H. Lee P.B. Oh T.K. Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy? J. Clin. Anesth. 2015 27 4 296 300 10.1016/j.jclinane.2015.02.006 25792176
    [Google Scholar]
  63. Song D. He A. Xu R. Xiu X. Wei Y. Efficacy of pain relief in different postherpetic neuralgia therapies: A network meta-analysis. Pain Physician 2018 21 1 19 32 29357328
    [Google Scholar]
  64. Bennett D.L. Clark A.J. Huang J. Waxman S.G. Dib-Hajj S.D. The role of voltage-gated sodium channels in pain signaling. Physiol. Rev. 2019 99 2 1079 1151 10.1152/physrev.00052.2017 30672368
    [Google Scholar]
  65. Dib-Hajj S.D. Waxman S.G. Sodium channels in human pain disorders: Genetics and pharmacogenomics. Annu. Rev. Neurosci. 2019 42 1 87 106 10.1146/annurev‑neuro‑070918‑050144 30702961
    [Google Scholar]
  66. Tong C. Zhengyao Z. Mei L. Dongpo S. Qian H. Fengqun M. Pregabalin and gabapentin in patients with spinal cord injury-related neuropathic pain: A network meta-analysis. Pain Ther. 2021 10 2 1497 1509 10.1007/s40122‑021‑00302‑8 34491542
    [Google Scholar]
  67. Hagen E.M. Rekand T. Management of neuropathic pain associated with spinal cord injury. Pain Ther. 2015 4 1 51 65 10.1007/s40122‑015‑0033‑y 25744501
    [Google Scholar]
  68. Taylor C.P. The biology and pharmacology of calcium channel alpha2-delta proteins pfizer satellite symposium to the 2003 society for neuroscience meeting. sheraton new orleans hotel, new orleans, la november 10, 2003. CNS Drug Rev. 2004 10 2 183 188 10.1111/j.1527‑3458.2004.tb00012.x 15317151
    [Google Scholar]
  69. Cao X. Shen Z. Wang X. Zhao J. Liu W. Jiang G. A meta-analysis of randomized controlled trials comparing the efficacy and safety of pregabalin and gabapentin in the treatment of postherpetic neuralgia. Pain Ther. 2023 12 1 1 18 10.1007/s40122‑022‑00451‑4 36334235
    [Google Scholar]
  70. Gou X. Yu X. Bai D. Tan B. Cao P. Qian M. Zheng X. Chen L. Shi Z. Li Y. Ye F. Liang Y. Ni J. Pharmacology and mech-anism of action of hsk16149, a selective ligand of α2δ subunit of voltage-gated calcium channel with analgesic activity in animal models of chronic pain. J. Pharmacol. Exp. Ther. 2021 376 3 330 337 10.1124/jpet.120.000315 33293377
    [Google Scholar]
  71. Zhang D. Lei T. Qin L. Li C. Lin X. Wang H. Zhang G. Zhang S. Shi K. Li L. Yang Z. Yang X. Ba X. Gao Y. Zhang Z. Wang G. Wu L. Wang Y. Wang Y. Zhu S. Shi J. Ye Z. Yang C. Liu C. Zhang T. Lu S. Yu N. Li X. Han X. Chen X. Wan L. Cheng Z. Bai N. Jin Z. Yu C. Zhang W. Lu J. Wang D. Sun H. Wu W. Qin P. Feng Z. Chen R. Zhang T. Yang D. Yin W. Zhang J. Li X. Li F. Wu T. Lu Q. Efficacy and safety of crisugabalin (HSK16149) in adults with postherpetic neuralgia. JAMA Dermatol. 2024 160 11 1182 1191 10.1001/jamadermatol.2024.3410 39320907
    [Google Scholar]
  72. Chen Q. Wu Q. Song R. Wang Y. Zhang M. Li F. Zeng W. Wang W. Jia J. Yu C. Liu Y. A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects. Front. Pharmacol. 2023 14 1296672 10.3389/fphar.2023.1296672 38146463
    [Google Scholar]
  73. Zhang M. Jia X. Cheng C. Wang Y. Li Y. Kong L. Li Q. Xie F. Yu Y. He Y. Dong Q. Jia Z. Wang Y. Xu A. Capsaicin functions as a selective degrader of STAT3 to enhance host resistance to viral infection. Acta Pharmacol. Sin. 2023 44 11 2253 2264 10.1038/s41401‑023‑01111‑9 37311796
    [Google Scholar]
  74. Jeon Y.H. Herpes zoster and postherpetic neuralgia: Practical consideration for prevention and treatment. Korean J. Pain 2015 28 3 177 184 10.3344/kjp.2015.28.3.177 26175877
    [Google Scholar]
  75. Kitagawa Y. Tamai I. Hamada Y. Usui K. Wada M. Sakata M. Matsushita M. Orally administered selective TRPV1 antagonist, JTS-653, attenuates chronic pain refractory to non-steroidal anti-inflammatory drugs in rats and mice including post-herpetic pain. J. Pharmacol. Sci. 2013 122 2 128 137 10.1254/jphs.12276FP 23728381
    [Google Scholar]
  76. Vicuña L. Strochlic D.E. Latremoliere A. Bali K.K. Simonetti M. Husainie D. Prokosch S. Riva P. Griffin R.S. Njoo C. Gehrig S. Mall M.A. Arnold B. Devor M. Woolf C.J. Liberles S.D. Costigan M. Kuner R. The serine protease inhibitor SerpinA3N atten-uates neuropathic pain by inhibiting T cell–derived leukocyte elastase. Nat. Med. 2015 21 5 518 523 10.1038/nm.3852 25915831
    [Google Scholar]
  77. Bali K.K. Kuner R. Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component. Pain 2017 158 11 2243 2258 10.1097/j.pain.0000000000001032 28837503
    [Google Scholar]
  78. Liang X. Fan Y. Bidirectional two-sample mendelian randomization analysis reveals a causal effect of interleukin-18 levels on posther-petic neuralgia risk. Front. Immunol. 2023 14 1183378 10.3389/fimmu.2023.1183378 37304287
    [Google Scholar]
  79. Bae C. Wang J. Shim H.S. Tang S.J. Chung J.M. La J.H. Mitochondrial superoxide increases excitatory synaptic strength in spinal dorsal horn neurons of neuropathic mice. Mol. Pain 2018 14 1744806918797032 10.1177/1744806918797032 30152257
    [Google Scholar]
  80. De Logu F. Nassini R. Materazzi S. Carvalho Gonçalves M. Nosi D. Degl’Innocenti, R.D.; Marone, I.M.; Ferreira, J.; Li Puma, S.; Benemei, S.; Trevisan, G.; Monteiro de Araújo, S.D.; Patacchini, R.; Bunnett, N.W.; Geppetti, P. Schwann cell TRPA1 mediates neuroin-flammation that sustains macrophage-dependent neuropathic pain in mice. Nat. Commun. 2017 8 1 1887 10.1038/s41467‑017‑01739‑2 29192190
    [Google Scholar]
  81. Trevisan G. Benemei S. Materazzi S. De Logu F. De Siena G. Fusi C. Fortes Rossato M. Coppi E. Marone I.M. Ferreira J. Geppetti P. Nassini R. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. Brain 2016 139 5 1361 1377 10.1093/brain/aww038 26984186
    [Google Scholar]
  82. Yu X. Liu H. Hamel K.A. Morvan M.G. Yu S. Leff J. Guan Z. Braz J.M. Basbaum A.I. Dorsal root ganglion macrophages con-tribute to both the initiation and persistence of neuropathic pain. Nat. Commun. 2020 11 1 264 10.1038/s41467‑019‑13839‑2 31937758
    [Google Scholar]
  83. Bennett G.J. Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988 33 1 87 107 10.1016/0304‑3959(88)90209‑6 2837713
    [Google Scholar]
  84. Gandhi S. Muqit M.M. Stanyer L. Healy D.G. Abou-Sleiman P.M. Hargreaves I. Heales S. Ganguly M. Parsons L. Lees A.J. Latchman D.S. Holton J.L. Wood N.W. Revesz T. PINK1 protein in normal human brain and Parkinson’s disease. Brain 2006 129 7 1720 1731 10.1093/brain/awl114 16702191
    [Google Scholar]
  85. Guo W. Zhang B. Liu M. Zhang J. Feng Y. Based on virtual screening and simulation exploring the mechanism of plant-derived compounds with PINK1 to postherpetic neuralgia. Mol. Neurobiol. 2024 61 11 9184 9203 10.1007/s12035‑024‑04098‑4 38602654
    [Google Scholar]
  86. Verzosa A.L. McGeever L.A. Bhark S.J. Delgado T. Salazar N. Sanchez E.L. Herpes simplex virus 1 infection of neuronal and non-neuronal cells elicits specific innate immune responses and immune evasion mechanisms. Front. Immunol. 2021 12 644664 10.3389/fimmu.2021.644664 34135889
    [Google Scholar]
  87. Li L. Kovacs S.B. Jørgensen I. Larson H.N. Lazear H.M. Miao E.A. Role of caspases and gasdermin a during HSV-1 infection in mice. Viruses 2022 14 9 2034 10.3390/v14092034 36146839
    [Google Scholar]
  88. Ku C.C. Chang Y.H. Chien Y. Lee T.L. Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments. Cell Biosci. 2016 6 1 21 10.1186/s13578‑016‑0086‑6 26985360
    [Google Scholar]
  89. Kong E. Hua T. Li J. Li Y. Yang M. Ding R. Wang H. Wei H. Feng X. Han C. Yuan H. HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING. Brain 2024 147 7 2552 2565 10.1093/brain/awae053 38366606
    [Google Scholar]
  90. Chen K. Wei X. Zhang W. Wang R. Wang Y. Yang L. Bone morphogenetic protein 4 derived from the cerebrospinal fluid in patients with postherpetic neuralgia induces allodynia via the crosstalk between microglia and astrocyte. Brain Behav. Immun. 2024 119 836 850 10.1016/j.bbi.2024.05.007 38735405
    [Google Scholar]
  91. Zhang G.H. Lv M.M. Wang S. Chen L. Qian N.S. Tang Y. Zhang X.D. Ren P.C. Gao C.J. Sun X.D. Xu L.X. Spinal astrocytic activation is involved in a virally-induced rat model of neuropathic pain. PLoS One 2011 6 9 e23059 10.1371/journal.pone.0023059 21969850
    [Google Scholar]
  92. Kong C. Du J. Bu H. Huang C. Xu F. Ren H. LncRNA KCNA2-AS regulates spinal astrocyte activation through STAT3 to affect postherpetic neuralgia. Mol. Med. 2020 26 1 113 10.1186/s10020‑020‑00232‑9 33225882
    [Google Scholar]
  93. Sun R. Li S. Ren L. Xia Y. Wang Y. Bian Z. Fang J. Zhang Z. Efficacy of electroacupuncture for the treatment of postherpetic neuralgia: study protocol for a multicenter randomized controlled trial. J. Pain Res. 2022 15 959 968 10.2147/JPR.S357435 35411183
    [Google Scholar]
  94. Wu C. Lv Z. Zhao Y. Gao Y. Li J. Gao F. Meng X. Tian B. Shi J. Pan H. Li M. Electroacupuncture improves thermal and mechanical sensitivities in a rat model of postherpetic neuralgia. Mol. Pain 2013 9 1744-8069-9-18 10.1186/1744‑8069‑9‑18 23551937
    [Google Scholar]
  95. Zou J. Dong X. Wang K. Shi J. Sun N. Electroacupuncture inhibits autophagy of neuron cells in postherpetic neuralgia by increasing the expression of miR-223-3p. BioMed Res. Int. 2021 2021 1 6637693 10.1155/2021/6637693 33860046
    [Google Scholar]
  96. Wang L. Qiu L. Zheng X. Ouyang J. Zhang M. He L. Zeng S. Liu B. Peng J. Effectiveness of electroacupuncture at Jiaji acu-points (EX-B2), plus moxibustion and intermediate on postherpetic neuralgia: A randomized controlled trial. J. Tradit. Chin. Med. 2020 40 1 121 127 32227773
    [Google Scholar]
  97. Pei W. Zeng J. Lu L. Lin G. Ruan J. Is acupuncture an effective postherpetic neuralgia treatment? A systematic review and meta-analysis. J. Pain Res. 2019 12 2155 2165 10.2147/JPR.S199950 31410050
    [Google Scholar]
  98. Hu H. Shen Y. Li X. Tian H. Li X. Li Y. Cheng Y. Wu L. Han D. Efficacy of electroacupuncture therapy in patients with postherpetic neuralgia: Study protocol for a multicentre, randomized, controlled, assessor-blinded trial. Front. Med. 2021 8 624797 10.3389/fmed.2021.624797 34095161
    [Google Scholar]
  99. Lan Z. Wei Y. Yue K. He R. Jiang Z. Genetically predicted immune cells mediate the association between gut microbiota and neurop-athy pain. Inflammopharmacology 2024 32 5 3357 3373 10.1007/s10787‑024‑01514‑y 38955934
    [Google Scholar]
  100. Gonzalez-Alvarez M.E. Sanchez-Romero E.A. Turroni S. Fernandez-Carnero J. Villafañe J.H. Correlation between the altered gut microbiome and lifestyle interventions in chronic widespread pain patients: A systematic review. Medicina 2023 59 2 256 10.3390/medicina59020256 36837458
    [Google Scholar]
  101. Moloney R.D. Johnson A.C. O’Mahony S.M. Dinan T.G. Greenwood-Van Meerveld B. Cryan J.F. Stress and the microbiota-gut-brain axis in visceral pain: Relevance to irritable bowel syndrome. CNS Neurosci. Ther. 2016 22 2 102 117 10.1111/cns.12490 26662472
    [Google Scholar]
  102. Khaliq W. Alam S. Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst. Rev. 2007 2 CD004846 10.1002/14651858.CD004846.pub2 17443559
    [Google Scholar]
  103. Jiao B. Cao X. Zhang C. Zhang W. Yu S. Zhang M. Zhang X. Alterations of the gut microbiota in patients with postherpetic neural-gia. AMB Express 2023 13 1 108 10.1186/s13568‑023‑01614‑y 37803181
    [Google Scholar]
/content/journals/cn/10.2174/011570159X396405250924103619
Loading
Post-Herpetic Neuralgia: Review of Pathophysiology, Mechanisms, and Drug Treatment
Bentham Science Publishers ; https://doi.org/10.2174/011570159X396405250924103619
/content/journals/cn/10.2174/011570159X396405250924103619
/content/journals/cn/10.2174/011570159X396405250924103619
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: neural circuit ; pathogenesis ; neuropathic pain ; Herpes zoster ; drug therapy ; latent infection

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test